 3. Have a diagnosis of mucocutaneous leishmaniasis confirmed by microscopy of a stained smear of a lesion sample, by culture of a lesion sample, or by polymerase chain reaction PCR of a lesion sample or by Montenegro skin test and be willing to undergo treatment with miltefosine 